80.60
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$79.79
Aprire:
$79.92
Volume 24 ore:
7.17M
Relative Volume:
1.01
Capitalizzazione di mercato:
$102.32B
Reddito:
$393.94B
Utile/perdita netta:
$428.00M
Rapporto P/E:
210.66
EPS:
0.3826
Flusso di cassa netto:
$6.29B
1 W Prestazione:
+1.56%
1M Prestazione:
+5.32%
6M Prestazione:
+20.41%
1 anno Prestazione:
+75.18%
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CVS
Cvs Health Corp
|
80.60 | 101.29B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
346.85 | 309.53B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
374.77 | 81.49B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
283.91 | 74.56B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
277.57 | 33.08B | 126.36B | 1.30B | 1.55B | 10.67 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
US lawmakers seek testimony from five health insurers - Reuters
US Market Recap: How CVS Health Corporation stock reacts to monetary easingChart Signals & Consistent Return Investment Signals - ulpravda.ru
US Lawmakers Seek Testimony From Five Health Insurers - U.S. News & World Report
Cantor favors CVS and UNH for Medicare Advantage exposure in 2026 - Investing.com
The Truth About CVS Health Corp: Is This Quiet Giant Suddenly a Must?Cop Stock? - AD HOC NEWS
Are CVS, UnitedHealth, Cigna Hiding Billions In PBM Rebates? New Report Claims They Are - Benzinga
CVS, UnitedHealth, Cigna accused of diverting billions via shell firms - Investing.com
CVS Might Have to Fight Aetna Investor’s Appealed Disclosure Row - Bloomberg Law News
“Bullshit” — The New Way Health Giants Hide Billions - Hunterbrook
Southington, Glastonbury file federal lawsuits claiming diabetes drug manufacturers, PBMs collude on prices - Hartford Business Journal
CVS (CVS) Maintains Quarterly Dividend of $0.665 Per Share - GuruFocus
CVS Health declares quarterly dividend of $0.665 per share - Investing.com
CVS Health declares quarterly dividend of $0.665 per share By Investing.com - Investing.com Canada
CVS Health will pay shareholders 66.5 cents per share in February - Stock Titan
CVS Health price target raised to $91 from $87 at Bernstein - TipRanks
CVS Health Corporation (NYSE:CVS) is favoured by institutional owners who hold 88% of the company - simplywall.st
Are CVS, UnitedHealth, and Cigna Concealing Billions in PBM Rebates? A Recent Report Alleges They Are - Bitget
CVS Health Corporation $CVS Shares Bought by Alpha Omega Wealth Management LLC - MarketBeat
CVS Health Corp.: Can America’s Pharmacy Super-App Strategy Beat Amazon and Walmart? - AD HOC NEWS
JPMorgan Names CVS a Top Pick as Turnaround Gains Traction - Finviz
10 Top-Performing Dividend Stocks of 2025 - Morningstar
CVS Health (CVS) Poised for Continued Growth in 2026 - GuruFocus
CVS, Astra, Cardinal to continue record setting rally into 2026: Barron’s - Seeking Alpha
Insiders Scoop Unveiling The Lucrative Potential Of Cvs Health Director Salary Salaries Levels Fyi - shababeek.org
Econ Financial Services Corp Takes Position in CVS Health Corporation $CVS - MarketBeat
Unlocking The Secrets Of Cvs Health Director Salary A Comprehensive Guide Org Chrt In 2023 Dtbhn - shababeek.org
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock - Yahoo Finance
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
CVS Gets Higher Target as Bernstein Cites Management Confidence - Finviz
Peering Into CVS Health Corp's Recent Short Interest - Benzinga
Perigon Wealth Management LLC Grows Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Farmers & Merchants Investments Inc. - MarketBeat
Where is CVS Health Corporation (CVS) Headed According to Analysts? - Insider Monkey
CVS Health Corp.: Between Turnaround Hopes and Margin Squeeze, the Stock Walks a Tightrope - AD HOC NEWS
CVS Health Corp.: Dividend Doubts, Strategy Shifts and a Market Struggling to Believe - AD HOC NEWS
10 Best Affordable Healthcare Stocks to Buy Now - Insider Monkey
Rimfrost Patent Suit Targets Aker’s Krill Oil in CVS Supplements - Bloomberg Law News
Brookstone Capital Management Has $2.40 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Burney Co. Sells 45,923 Shares of CVS Health Corporation $CVS - MarketBeat
Check out CVS Health Corp's stock price (CVS-CA) in real time - CNBC
Canoe Financial LP Has $128.51 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Exchange Traded Concepts LLC Grows Position in CVS Health Corporation $CVS - MarketBeat
Are Markets Open On Christmas? Here's What's Open, What's Closed On December 25 - Benzinga
CVS Stock After the Bell (Dec. 24, 2025): CVS Health Dips in After‑Hours Holiday Trade—Key News, Forecasts, and What to Watch Before the Next Open - ts2.tech
CVS Health Corp (TSX:CVS) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CVS Health (CVS) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS/Aetna Medicare Advantage Plans Policy Holders Have - GlobeNewswire
Value Partners Investments Inc. Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health's (NYSE:CVS) investors will be pleased with their notable 84% return over the last year - Yahoo Finance
J&J Unit, CVS Take Aim at Big False Claims Act Judgments in 2026 - Bloomberg Law News
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):